Please assess the completion status of the following clinical trial:

Trial Title: Study of Dopamine Versus Vasopressin for Treatment of Low Blood Pressure in Low Birth Weight Infants

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Infants less than 24 hours of age~* Infants with birth weight of \<1001 grams and/or gestational age of \<29 weeks~* Not initiated on any continuous pressor therapy prior to enrollment~* Intravenous line in place~* Outborn infants meeting eligibility criteria~Exclusion Criteria:~* Infants not meeting eligibility criteria~* Infants with life-threatening congenital defects~* Infants with congenital hydrops~* Infants with frank hypovolemia (perinatal history consistent with decreased circulating blood volume plus clinical signs of hypovolemia)~* Infants with other unresolved causes of hypotension (air leaks, lung overdistention, or metabolic abnormalities).

- Gender: ALL
- Minimum Age: None
- Maximum Age: 24 Hours
- Healthy Volunteers: f

Study Arms:
- Dopamine treatment (Type: ACTIVE_COMPARATOR): Dopamine treatment beginning at 5 mcg/kg/min and titrated by 5 mcg/kg/min to effect up to maximum of 20 mcg/kg/min
- Vasopressin treatment (Type: ACTIVE_COMPARATOR): Arginine Vasopressin treatment beginning at 0.01 units/kg/hr and titrated up by 0.01 units/kg/hr to effect up to a maximum of 0.04 units/kg/hr
- Comparison Arm (Type: NO_INTERVENTION): Infants who did not require vasopressor support for hypotension during the first 24 hours of life

Based on this trial design, predict the completion outcome and termination type (if applicable).